NCT06745336

Clinical Study of CS-001 As a Treatment for Canities (Grey Hair)

• Status: Not Yet Recruiting
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 240 (estimated)
• Sponsor: Applied Biology, Inc. · Industry
• Sex: All
• Age: 30 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

Clinical Study to Assess the Safety and Efficacy of CS-001 as a treatment for Canities (Grey Hair)

Detailed description

CS-001 is a small molecule that affects lysosomal storage and transfer of melanin from hair follicle melanocytes. In vitro and a small pilot study demonstrated re-pigmentation of grey hair following CS-001 application. The aim of this study is to assess the safety and efficacy of CS-001 as a treatment for grey hair.

Conditions

• Canities
• Grey Hair

Interventions

Type	Name	Description
DRUG	CS-001	CS-001 Topical Treatment
DRUG	Placebo Topical Solution	Placebo Topical Solution

Timeline

• Start date: 2025-06-15
• Primary completion: 2027-06-15
• Completion: 2027-09-15
• First posted: 2024-12-20
• Last updated: 2024-12-24